In 1974, Merck Millipore was the first to market a closed filtration device: Steritest?. Since this time, through dedicated research & development, we have been instrumental in raising the industry?s ...

MilliporeSigma, the life science business of Germany-based Merck KGaA, reports that it is investing €35 million ($37 million) in biosafety testing at its Glasgow and Stirling sites in Scotland. The ...

MilliporeSigma has expanded its biosafety testing laboratories in Shanghai, China, with the completion of new lab space at its new €29 million (US$43 million) Biologics Testing Center. MilliporeSigma, ...

Proprietary Aptegra ™ platform reduces five assays to one Results in 66% faster testing time and significantly lower cost for clients compared to traditional methods Only platform that meets all ...